Examining the Circadian Timing Effects of the Hypotensive Response to Exercise

NCT ID: NCT07049783

Last Updated: 2025-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-22

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to learn how exercise timing affects blood pressure in adults with elevated or high blood pressure. Exercise can influence the body's natural 24-hour rhythms, including blood pressure patterns. A single exercise session can lower blood pressure for up to 24 hours, but it is not fully understood how the time-of-day for exercise affects this response. The main question this study aims to answer is:

• When the same participant exercises at different times of day (morning, afternoon, or evening), how does this affect the participant's blood pressure over the next 24 hours?

Participants will:

* Undergo an in-lab assessment of individual biological rhythm that will indicate the clock-time for an individual's biological night
* Complete 3 supervised treadmill exercise sessions

* 1 in the biological morning (biological night + 10 hours)
* 1 in the biological afternoon (biological night + 15 hours)
* 1 in the biological evening (biological night + 20 hours)
* Complete a 24-hour blood pressure assessment before and after each exercise session

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This fully counterbalanced, within-subject, randomized crossover trial will examine the time-of-day dependent hypotensive effect of exercise in adults aged 18-39 years with elevated blood pressure or stage 1 hypertension. To examine this, participants will complete an assessment of dim-light melatonin onset (DLMO), the gold standard assessment of individual circadian phase, which will be used to subsequently prescribe three exercise sessions in the morning (10 hours after DLMO), afternoon (15 hours after DLMO), and evening (20 hours after DLMO) with 24-hour blood pressure assessment before and after each exercise sessions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Young Adults Hypertension Post-Exercise Hypotension Circadian Rhythm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Morning

Exercise 10 hours after dim-light melatonin onset

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

A single standardized, in-lab, 30-minute monitored treadmill exercise session

Afternoon

Exercise 15 hours after dim-light melatonin onset

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

A single standardized, in-lab, 30-minute monitored treadmill exercise session

Evening

Exercise 20 hours after dim-light melatonin onset

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

A single standardized, in-lab, 30-minute monitored treadmill exercise session

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

A single standardized, in-lab, 30-minute monitored treadmill exercise session

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-39 Years old
* Resting blood pressure greater than or equal to 120/80 mmHg or less than 140/90 mmHg

Exclusion Criteria

* Diagnosis or history of chronic or autoimmune disease (i.e., cardiovascular, metabolic, renal, endocrine, cancer)
* Diagnosis or history of sleep disorder (i.e., obstructive sleep apnea, insomnia, restless leg syndrome)
* Alcohol or drug dependence
* Elevated risk for sleep disorders
* Elevated risk for clinical depression
* Normotensive (blood pressure less than 120/80 mmHg) or stage 2+ hypertension (blood pressure greater than or equal to 140/90 mmHg)
* Body mass index less than 18.5 or greater than 35 kg/m2
* Self-reported use of sleep medications/supplements (e.g., melatonin)
* Self-reported use of medications influencing vascular physiology (e.g., antihypertensive medications, weight loss medications)
* Highly physically active (greater than or equal to 300 minutes moderate-to-vigorous physical activity per week)
* Currently pregnant or breastfeeding
* Current tobacco use (greater than or equal to 1 cigarette in the past month)
* Nighttime or rotating shift work within the last 3 months
* Contraindications to aerobic exercise
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Freda Patterson

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Freda Patterson

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Delaware

Newark, Delaware, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Freda Patterson, PhD

Role: CONTACT

302-831-6588

Thomas Keiser

Role: CONTACT

302-831-6588

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thomas Keiser

Role: primary

302-831-6588

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2324519-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Timed Exercise Study
NCT04097886 COMPLETED NA